UBS Group’s Black Diamond Therapeutics BDTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $778K | Buy |
313,700
+185,906
| +145% | +$461K | ﹤0.01% | 4535 |
|
|
2025
Q1 | $198K | Buy |
127,794
+77,901
| +156% | +$121K | ﹤0.01% | 5325 |
|
|
2024
Q4 | $107K | Buy |
49,893
+11,436
| +30% | +$24.5K | ﹤0.01% | 5615 |
|
|
2024
Q3 | $167K | Buy |
38,457
+11,923
| +45% | +$51.9K | ﹤0.01% | 4834 |
|
|
2024
Q2 | $124K | Buy |
26,534
+22,263
| +521% | +$104K | ﹤0.01% | 4901 |
|
|
2024
Q1 | $21.7K | Buy |
4,271
+284
| +7% | +$1.44K | ﹤0.01% | 5723 |
|
|
2023
Q4 | $11.2K | Buy |
3,987
+3,741
| +1,521% | +$10.5K | ﹤0.01% | 6197 |
|
|
2023
Q3 | $706 | Sell |
246
-8,273
| -97% | -$23.7K | ﹤0.01% | 7176 |
|
|
2023
Q2 | $43K | Buy |
+8,519
| New | +$43K | ﹤0.01% | 5496 |
|
|
2023
Q1 | – | Sell |
-3,433
| Closed | -$6.18K | – | 8479 |
|
|
2022
Q4 | $6.18K | Sell |
3,433
-1,942
| -36% | -$3.5K | ﹤0.01% | 7874 |
|
|
2022
Q3 | $9K | Sell |
5,375
-12,224
| -69% | -$20.5K | ﹤0.01% | 7457 |
|
|
2022
Q2 | $44K | Sell |
17,599
-3,221
| -15% | -$8.05K | ﹤0.01% | 4997 |
|
|
2022
Q1 | $58K | Sell |
20,820
-8,734
| -30% | -$24.3K | ﹤0.01% | 5327 |
|
|
2021
Q4 | $157K | Buy |
29,554
+12,733
| +76% | +$67.6K | ﹤0.01% | 4845 |
|
|
2021
Q3 | $143K | Buy |
16,821
+5,454
| +48% | +$46.4K | ﹤0.01% | 4510 |
|
|
2021
Q2 | $139K | Sell |
11,367
-31,822
| -74% | -$389K | ﹤0.01% | 4594 |
|
|
2021
Q1 | $1.05M | Buy |
+43,189
| New | +$1.05M | ﹤0.01% | 3312 |
|
|
2020
Q4 | – | Sell |
-197
| Closed | -$6K | – | 7340 |
|
|
2020
Q3 | $6K | Sell |
197
-4,457
| -96% | -$136K | ﹤0.01% | 6322 |
|
|
2020
Q2 | $196K | Sell |
4,654
-2,577
| -36% | -$109K | ﹤0.01% | 4012 |
|
|
2020
Q1 | $180K | Buy |
+7,231
| New | +$180K | ﹤0.01% | 3967 |
|